These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2855543

  • 1. [Effects of converting enzyme inhibition by enalapril on renal hemodynamics in essential arterial hypertension].
    Chaignon M, Moreau L.
    Presse Med; 1988 Oct 08; 17(34):1745-7. PubMed ID: 2855543
    [Abstract] [Full Text] [Related]

  • 2. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.
    Kidney Int; 2002 Apr 08; 61(4):1462-8. PubMed ID: 11918753
    [Abstract] [Full Text] [Related]

  • 3. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D, Navis GJ, Donker AJ, de Jong PE.
    J Hypertens Suppl; 1983 Oct 08; 1(1):93-7. PubMed ID: 6100614
    [Abstract] [Full Text] [Related]

  • 4. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT, Mosley CA, Cervenka J, Bernstein KN.
    J Hypertens Suppl; 1984 Dec 08; 2(2):S89-92. PubMed ID: 6100882
    [Abstract] [Full Text] [Related]

  • 5. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG, Gillen G, Dargie HJ.
    Eur Heart J; 1988 Feb 08; 9(2):132-41. PubMed ID: 2832173
    [Abstract] [Full Text] [Related]

  • 6. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Feb 08; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP, Natov S, Boitard C, Lacour B, Grünfeld JP.
    Nephrol Dial Transplant; 1996 Apr 08; 11(4):673-8. PubMed ID: 8671857
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.
    Eur J Med; 1992 Sep 08; 1(5):268-72. PubMed ID: 1341608
    [Abstract] [Full Text] [Related]

  • 12. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct 08; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 13. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE.
    Clin Invest Med; 1991 Dec 08; 14(6):642-51. PubMed ID: 1665407
    [Abstract] [Full Text] [Related]

  • 14. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M, Barrou Z, Ayad M, Lucsko M, Aubert P, Perret L, Guedon J.
    J Hypertens Suppl; 1988 Dec 08; 6(3):S61-4. PubMed ID: 3225690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec 08; 25(12):656-9. PubMed ID: 2830196
    [Abstract] [Full Text] [Related]

  • 17. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G.
    Kidney Int Suppl; 1996 Jun 08; 55():S91-3. PubMed ID: 8743521
    [Abstract] [Full Text] [Related]

  • 18. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G.
    Clin Exp Pharmacol Physiol; 2005 Oct 08; 32(10):865-70. PubMed ID: 16173949
    [Abstract] [Full Text] [Related]

  • 19. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
    Navis GJ, de Zeeuw D, de Jong PE.
    J Cardiovasc Pharmacol; 1986 Oct 08; 8 Suppl 1():S30-4. PubMed ID: 2422491
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P, Cody RJ, Sealey JE, Laragh JH.
    Am J Hypertens; 1989 Aug 08; 2(8):599-603. PubMed ID: 2550029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.